All this information was known in the Quaterly at the end of July.
It is a question of whether you are investing for the long term or short term. It is unrealistic to expect significant increases in revenue over a short time frame. Signing up centers overseas is the first priority and as acceptance increase, sales will increase but it will take time and there will be cash burns until revenues start to match expenditure.
Either invest or trade.
News: Admedus revenue up 7.09% for FY2014, page-13
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |